Pharmacovigilance and Risk Management

Pharmacovigilance and Risk Management comprises set of Pharmacovigilance activities and interventions designed to identify, characterize, prevent or minimize risks relating to medicinal and therapeutic products including the assessment of the effectiveness of their clinical interventions and combination therapies. Drug industry need to promote companies in pharmacovigilance practice to use information technology and to review software’s used in pharmacovigilance and clinical trials.


  • Risk communication: Interface between pharmacovigilance, sales and marketing
  • Implementation of Risk Minimization Plans
  • Information technology in pharmacovigilance and promoting companies

Related Conference of Pharmacovigilance and Risk Management

May 09-10, 2024

4th Global Summit on Pharmaceutical Research

Barcelona, Spain
May 16-17, 2024

18th World Drug Delivery Summit

Rome, Italy
May 30-31, 2024

9th Pharmaceutical Chemistry Conference

Paris, France
July 25-26, 2024

34th Annual European Pharma Congress

Frankfurt, Germany
September 11-12, 2024

9th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
September 25-26, 2024

4th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2024

3rd World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2024

3rd World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 28-29, 2024

12th International Conference on Clinical Trials

Vancouver, Canada
November 28-29, 2024

39th World Congress on Pharmacology and Therapeutics

Paris, France
November 28-29, 2024

4th International Conference on Pharmaceutical Chemistry

Bali, Indonesia
December 05-06, 2024

17th World Drug Delivery Summit

Dubai, UAE

Pharmacovigilance and Risk Management Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in